Author : United States. Congress. House. Committee on Science, Space, and Technology. Subcommittee on Transportation, Aviation, and Materials
Publisher :
Page : 160 pages
File Size : 42,3 MB
Release : 1990
Category : Competition, International
ISBN :
Author :
Publisher :
Page : 72 pages
File Size : 34,73 MB
Release : 1985
Category : Federal aid to research
ISBN :
Author : United States. Congress. Office of Technology Assessment
Publisher : DIANE Publishing
Page : 61 pages
File Size : 19,60 MB
Release : 1985
Category : Federal aid to research
ISBN : 1428923470
Author : United States. Congress. House. Committee on Government Operations. Research and Technical Programs Subcommittee
Publisher :
Page : 220 pages
File Size : 40,14 MB
Release : 1966
Category : Research
ISBN :
Author : United States. Congress. House. Government Operations
Publisher :
Page : 218 pages
File Size : 34,51 MB
Release : 1966
Category :
ISBN :
Author : United States. Congress. Senate. Committee on Appropriations. Subcommittee on Commerce, Justice, State, the Judiciary, and Related Agencies
Publisher :
Page : 992 pages
File Size : 20,60 MB
Release : 1997
Category : Political Science
ISBN :
Distributed to some depository libraries in microfiche.
Author : United States. Congress. House. Committee on Science, Space, and Technology
Publisher :
Page : 296 pages
File Size : 24,11 MB
Release : 1990
Category :
ISBN :
Author : United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Merchant Marine
Publisher :
Page : 66 pages
File Size : 48,7 MB
Release : 1990
Category : Maritime
ISBN :
Author : United States. Congress. House. Committee on Merchant Marine and Fisheries. Subcommittee on Merchant Marine
Publisher :
Page : 172 pages
File Size : 42,74 MB
Release : 1987
Category : United States
ISBN :
Author : Congressional Budget Office
Publisher : Lulu.com
Page : 65 pages
File Size : 25,1 MB
Release : 2013-06-09
Category : Science
ISBN : 1304121445
Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...
